Literature DB >> 34426907

Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.

Zuné Jansen van Rensburg1, Shameemah Abrahams1,2, Soraya Bardien3,4, Colin Kenyon5,6,7.   

Abstract

Parkinson's disease (PD) is a movement disorder associated with severe loss of mainly dopaminergic neurons in the substantia nigra. Pathological hallmarks include Lewy bodies, and loss of neuromelanin, due to degeneration of neuromelanin-containing dopaminergic neurons. Despite being described over 200 years ago, the etiology of PD remains unknown. Here, we highlight the roles of reactive oxygen species (ROS), iron, alpha synuclein (α-syn) and neuromelanin in a toxic feedback loop culminating in neuronal death and spread of the disease. Dopaminergic neurons are particularly vulnerable due to decreased antioxidant concentration with aging, constant exposure to ROS and presence of neurotoxic compounds (e.g. ortho-quinones). ROS and iron increase each other's levels, creating a state of oxidative stress. α-Syn aggregation is influenced by ROS and iron but also increases ROS and iron via its induced mitochondrial dysfunction and ferric-reductase activity. Neuromelanin's binding affinity is affected by increased ROS and iron. Furthermore, during neuronal death, neuromelanin is degraded in the extracellular space, releasing its bound toxins. This cycle of events continues to neighboring neurons in the form of a toxic loop, causing PD pathology. The increase in ROS and iron may be an important target for therapies to disrupt this toxic loop, and therefore diets rich in certain 'nutraceuticals' may be beneficial. Turmeric is an attractive candidate, as it is known to have anti-oxidant and iron chelating properties. More studies are needed to test this theory and if validated, this would be a step towards development of lifestyle-based therapeutic modalities to complement existing PD treatments.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alpha-synuclein; Iron; Neuromelanin; Parkinson’s disease; Reactive oxygen species; Toxic feedback loop

Mesh:

Substances:

Year:  2021        PMID: 34426907     DOI: 10.1007/s12035-021-02516-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  141 in total

1.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 2.  Genetic risk factors in Parkinson's disease.

Authors:  K J Billingsley; S Bandres-Ciga; S Saez-Atienzar; A B Singleton
Journal:  Cell Tissue Res       Date:  2018-03-13       Impact factor: 5.249

3.  Proteomic identification of novel proteins in cortical lewy bodies.

Authors:  James B Leverenz; Imran Umar; Qing Wang; Thomas J Montine; Pamela J McMillan; Debby W Tsuang; Jinghua Jin; Catherine Pan; Jenny Shin; David Zhu; Jing Zhang
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

4.  In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.

Authors:  W P Gai; H X Yuan; X Q Li; J T Power; P C Blumbergs; P H Jensen
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

5.  Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey.

Authors:  Hyon K Choi; Simin Liu; Gary Curhan
Journal:  Arthritis Rheum       Date:  2005-01

6.  Prevalence of parkinsonian signs and associated mortality in a community population of older people.

Authors:  D A Bennett; L A Beckett; A M Murray; K M Shannon; C G Goetz; D M Pilgrim; D A Evans
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

Review 7.  The hallmarks of Parkinson's disease.

Authors:  Paul M A Antony; Nico J Diederich; Rejko Krüger; Rudi Balling
Journal:  FEBS J       Date:  2013-06-10       Impact factor: 5.542

Review 8.  Non-motor symptoms: identification and management.

Authors:  Sharon Muzerengi; Donatella Contrafatto; K Ray Chaudhuri
Journal:  Parkinsonism Relat Disord       Date:  2007       Impact factor: 4.891

Review 9.  The Evolution of Genetics: Alzheimer's and Parkinson's Diseases.

Authors:  Andrew Singleton; John Hardy
Journal:  Neuron       Date:  2016-06-15       Impact factor: 17.173

10.  The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.

Authors:  Anne-Laure Mahul-Mellier; Johannes Burtscher; Niran Maharjan; Laura Weerens; Marie Croisier; Fabien Kuttler; Marion Leleu; Graham W Knott; Hilal A Lashuel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

View more
  3 in total

Review 1.  Iron Metabolism in Aging and Age-Related Diseases.

Authors:  Yao Tian; Yuanliangzi Tian; Zhixiao Yuan; Yutian Zeng; Shuai Wang; Xiaolan Fan; Deying Yang; Mingyao Yang
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

Review 2.  Nutrition and Gut-Brain Pathways Impacting the Onset of Parkinson's Disease.

Authors:  Damiano Terenzi; Anne-Katrin Muth; Soyoung Q Park
Journal:  Nutrients       Date:  2022-07-06       Impact factor: 6.706

Review 3.  The Potential Role of Voltage-Dependent Anion Channel in the Treatment of Parkinson's Disease.

Authors:  Yajie He; Wenjun Wang; Ting Yang; Elizabeth Rosalind Thomas; Rongyang Dai; Xiang Li
Journal:  Oxid Med Cell Longev       Date:  2022-10-05       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.